rs142607078
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS1
The NM_020944.3(GBA2):c.1196G>C(p.Arg399Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00226 in 1,613,942 control chromosomes in the GnomAD database, including 8 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_020944.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GBA2 | NM_020944.3 | c.1196G>C | p.Arg399Pro | missense_variant | 7/17 | ENST00000378103.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GBA2 | ENST00000378103.7 | c.1196G>C | p.Arg399Pro | missense_variant | 7/17 | 1 | NM_020944.3 | P1 | |
GBA2 | ENST00000378094.4 | c.1196G>C | p.Arg399Pro | missense_variant | 7/17 | 1 | |||
GBA2 | ENST00000467252.5 | n.768G>C | non_coding_transcript_exon_variant | 4/13 | 1 |
Frequencies
GnomAD3 genomes ? AF: 0.00137 AC: 209AN: 152144Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00132 AC: 332AN: 251210Hom.: 0 AF XY: 0.00135 AC XY: 183AN XY: 135804
GnomAD4 exome AF: 0.00235 AC: 3435AN: 1461798Hom.: 8 Cov.: 32 AF XY: 0.00219 AC XY: 1590AN XY: 727216
GnomAD4 genome ? AF: 0.00137 AC: 209AN: 152144Hom.: 0 Cov.: 32 AF XY: 0.00143 AC XY: 106AN XY: 74334
ClinVar
Submissions by phenotype
not provided Uncertain:2Benign:4
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Jul 30, 2021 | Reported in an individual with sporadic spasticity, however, a second variant was not discussed and segregation studies were not provided (Ngo et al., 2019); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 31692161) - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Aug 01, 2023 | GBA2: BP4 - |
Likely benign, no assertion criteria provided | clinical testing | Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC) | - | - - |
Likely benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Likely benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | - | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Jun 01, 2022 | - - |
Spastic paraplegia Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Invitae | Jan 29, 2024 | - - |
Hereditary spastic paraplegia Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Genome Diagnostics Laboratory, The Hospital for Sick Children | Aug 11, 2020 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at